ATORvastatin in Pulmonary TUBerculosis: a POPulation PharmacoKinetics -PharmacoDynamics Sub-study (ATORTUB popPK-PD)

NCT07303699 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Pulmonary Tuberculosis (TB)

Interventions

DRUG: Atorvastatin 20 mg
DRUG: Atorvastatin 40 mg
DRUG: Atorvastatin 60 mg
DRUG: Fixed dose combination of Rifampicin (R) Isoniazid (H) Pyrazinamid (Z) Ethambutol (E)

Sponsor

Obafemi Awolowo University Teaching Hospital

Collaborators

[object Object]
[object Object]